Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02460263 · ClinicalTrials.gov registry record · NA
The EvAluation of TaBlo In-CLinic and In-HOme
A NA study, sponsored by Outset Medical.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02460263 is a NA study that has completed, run by Outset Medical. The registered enrollment target is 30 participants.
The verdict
NCT02460263, a NA study, has completed, sponsored by Outset Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the Tablo Hemodialysis System when used In-Center by trained individuals and In-Home by trained Subjects.
Interventions
- DEVICE Tablo Hemodialysis System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-12 |
| Est. Completion | 2019-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02460263
The ClinicalTrials.gov registry entry for NCT02460263 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Outset Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tablo Hemodialysis System is the first listed.
NCT02460263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02460263 about?
NCT02460263 is a clinical study titled "The EvAluation of TaBlo In-CLinic and In-HOme". The purpose of this study is to evaluate the Tablo Hemodialysis System when used In-Center by trained individuals and In-Home by trained Subjects.
What is the current status of trial NCT02460263?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-12. Estimated completion is 2019-05.
What interventions are being tested in trial NCT02460263?
The interventions under investigation include: Tablo Hemodialysis System (DEVICE).
Who is sponsoring clinical trial NCT02460263?
This trial is sponsored by Outset Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.